Tag: baby-boomer

Investment Services & Trading Picture Gallery

Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.; Price Target $3.50

April 4, 2013
Presse

Eye Drop in Clinical Testing for Treatment of Wet-AMD

Continue Reading